|View printer-friendly version|
|December 18, 2002 4:29 p.m.|
|Teva Announces the Grant of Summary Judgement for Mirtazapine Tablets, Generic Version of Remeron|
Jerusalem, Israel, December 18, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of New Jersey has granted summary judgment in Teva's favor on the issue of non-infringement with regard to Organon's Remeron® Patent No. 5,977,099.